Table 3.
Changes in clinical parameters between baseline and follow-up examinations in subjects who underwent three or more health examinations (n = 5,033).
| Changes in parameters | BMI < 18.5 | 18.5 ≤ BMI < 23.0 | 23.0 ≤ BMI < 25.0 | BMI ≥ 25.0 | P |
|---|---|---|---|---|---|
| ΔWeight (kg) | 0.7 ± 1.5 | 0.3 ± 1.7 | − 0.1 ± 2.1 | − 0.5 ± 2.3 | < 0.001 |
| ΔSMI_Wt | − 0.9 ± 2.1 | − 0.4 ± 2.1 | 0.0 ± 2.2 | 0.3 ± 2.3 | < 0.001 |
| ΔFP (%) | 0.8 ± 1.9 | 0.4 ± 1.8 | 0.0 ± 1.9 | − 0.3 ± 2.0 | < 0.001 |
| ΔSBP (mmHg) | − 0.2 ± 8.1 | − 0.2 ± 10.0 | − 1.6 ± 10.7 | − 1.6 ± 10.9 | < 0.001 |
| ΔDBP (mmHg) | − 0.1 ± 6.2 | − 0.5 ± 6.5 | − 1.0 ± 6.6 | − 1.2 ± 6.7 | 0.012 |
| ΔHDL (mg/dL) | 0.2 ± 7.1 | − 0.1 ± 6.5 | 0.0 ± 6.3 | 0.4 ± 5.9 | 0.230 |
| ΔTG (mg/dL) | 1.7 ± 26.5 | 3.4 ± 32.1 | 0.0 ± 39.6 | − 2.5 ± 50.4 | < 0.001 |
| ΔGlucose (mg/dL) | 1.3 ± 6.7 | 0.5 ± 7.9 | 0.9 ± 6.7 | 1.1 ± 10.7 | 0.081 |
BMI body mass index, SMI_Wt weight-adjusted skeletal muscle index, FP fat percentage, SBP systolic blood pressure, DBP diastolic blood pressure, HDL high-density lipoprotein, TG triglyceride.